Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells

Prostate

Volumn 73, Issue 14, 2013, Pages 1538-1546

  Vaughan, Roger A ^a,b   Garcia Smith, Randi ^b   Trujillo, Kristina A ^b   Bisoffi, Marco ^b,c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

glycolytic metabolism; inflammation; mitochondrial function; oxidative metabolism; prostate epithelial cell models; tumor necrosis factor alpha

Indexed keywords

CYTOCHROME C; GLUCOSE TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; AEROBIC METABOLISM; ARTICLE; CELL ENERGY; CELL STRAIN LNCAP; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; GLYCOLYSIS; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUMINESCENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

GLYCOLYTIC METABOLISM; INFLAMMATION; MITOCHONDRIAL FUNCTION; OXIDATIVE METABOLISM; PROSTATE EPITHELIAL CELL MODELS; TUMOR NECROSIS FACTOR ALPHA;

CELL LINE, TUMOR; CYTOCHROMES C; DISEASE PROGRESSION; ENERGY METABOLISM; EPITHELIAL CELLS; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HUMANS; INFLAMMATION; MALE; MITOCHONDRIA; OXIDATIVE STRESS; PPAR ALPHA; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC NEOPLASMS; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883202592     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22703     Document Type: Article

References (27)

1. Gueron G, De Siervi A, Vazquez E,. Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior. Prostate Cancer Prostat Dis 2012; 15 (3): 213-221.
2. Sfanos KS, De Marzo AM,. Prostate cancer and inflammation: The evidence. Histopathology 2012; 60 (1): 199-215.
3. Tse BW, Scott KF, Russell PJ,. Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer 2012; 2012: 128965.
4. Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T,. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. J Urol 2000; 164 (3 Pt 1): 800-805.
5. Lu L, Tang D, Wang L, Huang LQ, Jiang GS, Xiao XY, Zeng FQ,. Gambogic acid inhibits TNF-alpha-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-kappaB signaling pathways. Acta Pharmacol Sin 2012; 33 (4): 531-541.
6. Radhakrishnan P, Chachadi V, Lin MF, Singh R, Kannagi R, Cheng PW,. TNFalpha enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands. Biochem Biophys Res Commun 2011; 409 (3): 436-441.
7. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC,. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 1992; 140 (3): 539-544.
8. Schweigerer L, Malerstein B, Gospodarowicz D,. Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem Biophys Res Commun 1987; 143 (3): 997-1004.
9. Chopra DP, Menard RE, Januszewski J, Mattingly RR,. TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 2004; 203 (2): 145-154.
10. Lee EC, Zhan P, Schallhom R, Packman K, Tenniswood M,. Antiandrogen-induced cell death in LNCaP human prostate cancer cells. Cell Death Different 2003; 10 (7): 761-771.
11. Gorelik L, Bar-Dagan Y, Mokyr MB,. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells. J Immunol 1996; 156 (11): 4298-4308.
12. Kuhweide R, Van Damme J, Ceuppens JL,. Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth. Eur J Immunol 1990; 20 (5): 1019-1025.
13. Mocellin S, Rossi CR, Pilati P, Nitti D,. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 2005; 16 (1): 35-53.
14. Flavin R, Zadra G, Loda M,. Metabolic alterations and targeted therapies in prostate cancer. J Pathol 2011; 223 (2): 283-294.
15. Trock BJ,. Application of metabolomics to prostate cancer. Urol Oncol 2011; 29 (5): 572-581.
16. Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P,. The Warburg effect: Insights from the past decade. Pharmacol Ther 2013; 137 (3): 318-330.
17. Kim JW, Dang CV,. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006; 66 (18): 8927-8930.
18. Hochachka PW, Rupert JL, Goldenberg L, Gleave M, Kozlowski P,. Going malignant: The hypoxia-cancer connection in the prostate. BioEssays 2002; 24 (8): 749-757.
19. Costello LC, Feng P, Milon B, Tan M, Franklin RB,. Role of zinc in the pathogenesis and treatment of prostate cancer: Critical issues to resolve. Prostate cancer Prostat Dis 2004; 7 (2): 111-117.
20. Costello LC, Franklin RB,. The clinical relevance of the metabolism of prostate cancer; Zinc and tumor suppression: Connecting the dots. Mol Cancer 2006; 5: 17.
21. Singh KK, Desouki MM, Franklin RB, Costello LC,. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer 2006; 5: 14.
22. Vaughan RA, Garcia-Smith R, Dorsey J, Griffith JK, Bisoffi M, Trujillo KA,. Tumor necrosis factor alpha induced warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells. Int J Cancer 2013. doi: 10.1002/ijc.28264. [Epub ahead of print]
23. Garber K,. Energy deregulation: Licensing tumors to grow. Science 2006; 312 (5777): 1158-1159.
24. Gatenby RA, Gillies RJ,. Why do cancers have high aerobic glycolysis ? Nat Rev Cancer 2004; 4 (11): 891-899.
25. Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, Schwarz EM, Puzas JE, O'Keefe RJ,. NFkappaB: A pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res 2003; (415 Suppl): S75-S85.
26. Zu XL, Guppy M,. Cancer metabolism: Facts, fantasy, and fiction. Biochem Biophys Res Commun 2004; 313 (3): 459-465.
27. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP,. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell cycle 2010; 9 (17): 3506-3514.